Keywords: CEST & MT, Treatment, GliomaIn this prospective clinical study we compared the ability of asymmetry-based amide proton transfer-weighted (APTw) imaging with Lorentzian-fit-based (PeakAreaAPT and MTconst) and relaxation-compensated (MTRRexAPT and MTRRexMT) CEST-MRI of the amide proton transfer (APT) and semisolid magnetization transfer (ssMT) at 3T for the prediction of the overall survival of patients with glioma at the first follow-up after completion of radiotherapy. The APTw (HR=4.66, p<0.001) was more strongly associated with survival compared to the MTRRexAPT (HR=2.44, p=0.056) and MTconst (HR=2.54, p=0.044). The MTRRexMT and PeakAreaAPT did not display any association with survival.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords